Amid Possible Coming Enforcement, PhRMA Again Asks Court to Block Louisiana’s 340B Contract Pharmacy Law

In a recent federal court filing, Louisiana Attorney General Liz Murrill's office said it had not moved to enforce a state 340B contract pharmacy law.
After Louisiana signaled plans to possibly enforce its state 340B contract pharmacy law, a powerful drug industry trade group has [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Arkansas Looks to Amend Temporary Contract Pharmacy Agreement with Novo Nordisk

Arkansas Insurance Department office sign
The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.
After hospitals in Arkansas raised concerns over details of an agreement by Novo Nordisk to temporarily loosen contract pharmacy restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Arizona State Senators Introduce Latest 340B Contract Pharmacy Bill

Two influential Arizona state senators recently introduced a bill that would prohibit drugmaker restrictions on 340B contract pharmacy use.
Two high-ranking Republican Arizona state senators have introduced a bill that would bar drug manufacturer restrictions on 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provider-Drugmaker Lobbying Group Adds Two More Manufacturers

340B Working Table's lobbying disclosure filing.
A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added two more [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Health System’s Suit Against Drugmakers Seeks to Recover ‘Hundreds of Millions in Overpayments’

Calif-based Adventist Health System/West and four drugmakers are clashing in federal district court over allegations of 340B overcharges.
A California health system is continuing a previously sealed whistleblower case it first filed in 2021 against several pharmaceutical companies. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders

A Medicaid drug rebate policy change that recently took effect could lead to reduced 340B savings and drug discontinuations.
A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Iowa 340B Contract Pharmacy Bill Introduced; Companion Bills Debut in West Virginia, Oklahoma

Iowa is the latest state to introduce a bill to shield 340B contract pharmacy arrangements from manufacturer restrictions.
A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie Pushes to Block Louisiana 340B Contract Law, New State AG Takes Office

In a recent federal court filing, Louisiana Attorney General Liz Murrill's office said it had not moved to enforce a state 340B contract pharmacy law.
Pharmaceutical giant AbbVie recently urged a federal judge to rule on its suit against Louisiana’s 340B contract pharmacy law without [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two More States Introduce 340B Contract Pharmacy Protection Bills

Two high-ranking West Virginia state senators recently introduced a bipartisan bill that would prohibit drug manufacturer restrictions on 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Makers Issue Record Number of 340B Refunds in 2023, Merck First to Refund in 2024

Drugmakers issued a record 41 refunds to 340B covered entities in 2023.
Drugmakers issued a record 41 refunds to 340B covered entities in 2023. And Merck is the first to announce it [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live